- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02721303
Appetite Regulation in Older-Aged Obese Individuals
January 4, 2021 updated by: University of Colorado, Denver
This study plans to learn more about how age and weight impact appetite and food intake.
Specifically, this study is being done to see whether age and obesity impact appetite and the brain's response to food.
In this study the investigators will be evaluating how participants brains respond to food images as well as your food-related behaviors and hormones.
The investigators will be comparing older individuals aged 65 to 85 years who are normal weight compared to those who are obese.
The Investigators will then compare older aged individuals to younger adults aged 21 to 45 years.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
In a cross sectional design participants will be studied on one occasion after a 3-day diet run-in.
On the study day they will present in the fasting state, have an intravenous catheter placed for blood draws and have baseline blood samples taken and appetite measures performed.
Participants will then undergo functional magnetic resonance imaging (fMRI).
This will be followed by a breakfast meal.
Blood and appetite measures will be performed every half hour for 3 hours.
Repeat fMRI will be performed 30 minutes after the meal.
After three hours participants will be offered a buffet style lunch and then will be done with the study visit.
Study Type
Interventional
Enrollment (Actual)
37
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Univeristy of Colorado
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Older aged adults (O): 65-85
- Younger adults (Y): 21-45
- Obese (Ob): body mass index (BMI) 30-40
- Normal Weight (NW): BMI 18-25
Exclusion Criteria:
- Pregnancy;
- Advanced organ failure;
- Active cancer diagnosis;
- Uncontrolled hypertension or metabolic disorder;
- Cognitive impairment or psychiatric disease limiting ability to comply;
- Presently in an exercise or diet program;
- Recent weight loss of >5 lbs in past 6 mo.;
- Bariatric surgery;
- Use of any weight loss drugs;
- Use of any medication known to significantly affect appetite (anti-depressants are allowable);
- Present tobacco use;
- Use/abuse of substances of abuse including any marijuana use by history;
- Any contraindication to MRI;
- Claustrophobia;
- Body weight >300 lbs; and
- Inability to fit in MRI scanner.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: obese older aged, aged 65-85, BMI 30-40
Older aged patients who are obese and between the ages of 65-85 with a BMI between 30-40.
|
Participants will be studied on one occasion after a 3-day diet run-in.
This will be followed by a breakfast meal.
After a 3-day diet run-in, participants will undergo a functional magnetic resonance imaging procedure (fMRI).
Repeat fMRI will be performed 30 minutes after the meal.
Other Names:
On the study day participants will present in the fasting state, have an intravenous catheter placed for blood draws and have baseline blood samples taken.
Blood and appetite measures will be performed every half hour for 3 hours.
Other Names:
|
|
Active Comparator: normal weight older aged, aged 65-85, BMI 18-25
Older aged patients who are of normal weight and between the ages of 65-85 with a BMI between 18-25.
|
Participants will be studied on one occasion after a 3-day diet run-in.
This will be followed by a breakfast meal.
After a 3-day diet run-in, participants will undergo a functional magnetic resonance imaging procedure (fMRI).
Repeat fMRI will be performed 30 minutes after the meal.
Other Names:
On the study day participants will present in the fasting state, have an intravenous catheter placed for blood draws and have baseline blood samples taken.
Blood and appetite measures will be performed every half hour for 3 hours.
Other Names:
|
|
Active Comparator: obese younger aged, aged 21-45, BMI 30-40
Younger aged patients who are obese and between the ages of 21-45 with a BMI between 30-40 .
|
Participants will be studied on one occasion after a 3-day diet run-in.
This will be followed by a breakfast meal.
After a 3-day diet run-in, participants will undergo a functional magnetic resonance imaging procedure (fMRI).
Repeat fMRI will be performed 30 minutes after the meal.
Other Names:
On the study day participants will present in the fasting state, have an intravenous catheter placed for blood draws and have baseline blood samples taken.
Blood and appetite measures will be performed every half hour for 3 hours.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
neuronal response to food images
Time Frame: 1 day
|
fMRI of brain will be done in response to images of food
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2016
Primary Completion (Actual)
October 31, 2020
Study Completion (Actual)
October 31, 2020
Study Registration Dates
First Submitted
March 21, 2016
First Submitted That Met QC Criteria
March 23, 2016
First Posted (Estimate)
March 29, 2016
Study Record Updates
Last Update Posted (Actual)
January 6, 2021
Last Update Submitted That Met QC Criteria
January 4, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 15-1511
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on 3-day diet Run-in
-
Minneapolis Veterans Affairs Medical CenterCompletedType 2 DiabetesUnited States
-
Wageningen UniversityTop Institute Food and NutritionCompletedIdentify New Biomarkers in Blood or Urine After Consumption of Meat Protein, Dairy Protein and Grain Protein in Healthy Subjects.Netherlands
-
Hospital Parc Taulí, SabadellCompletedColorectal Neoplasms | Inflammatory Bowel Diseases | Colonoscopy | Colon Adenoma | Colon DiseaseSpain
-
GlaxoSmithKlineCompleted
-
Federico II UniversityCompleted
-
Wageningen UniversityAjinomoto Co., Inc.WithdrawnFood Intake Regulation | Umami Taste Perception | Sensory TestingNetherlands
-
Portuguese Oncology Institute, CoimbraCompletedColonic Neoplasms | Colon DiseasePortugal
-
University of Turin, ItalyRegione PiemonteCompletedRespiratory InsufficiencyItaly
-
OculisRecruitingDry Eye Disease (DED)United States
-
University of PittsburghAgency for Healthcare Research and Quality (AHRQ)CompletedCritical Care | Health Services | Transitional Care | Post-intensive Care SyndromeUnited States